These findings demonstrate that SCF possesses substantial anti-diarrheal activity, potentially mediated through dual modulation of the μ-opioid receptor and COX-2 pathways. SCF represents a promising natural candidate for further development as a therapeutic agent for diarrhea management.
Ahmmed et al. (Sun,) studied this question.